LivaNova PLC (LIVN)
Sector: Healthcare
Industry: Electromedical & Electrotherapeutic Apparatus
Country: United Kingdom
Exchange: NASDAQ
Market cap: $4.30B
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.
Latest financial period: June 30, 2026
Filed with the SEC: August 5, 2026
Estimated earnings date: November 4, 2026
Profit #424 of 1484 companies
| | Jun 26 | Mar 26 | Dec 25 | Sep 25 |
|---|
| ROIC | 15.8% | 15.5% | 10.5% | 8.1% |
Growth #567 of 1484 companies
Payout #1117 of 1484 companies
Safety #249 of 1484 companies
Price #762 of 1484 companies
